These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 7959190)

  • 1. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants.
    Suzuki M; Miura S; Mori M; Kai A; Suzuki H; Fukumura D; Suematsu M; Tsuchiya M
    Gut; 1994 Oct; 35(10):1375-8. PubMed ID: 7959190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury.
    Suzuki M; Miura S; Suematsu M; Fukumura D; Kurose I; Suzuki H; Kai A; Kudoh Y; Ohashi M; Tsuchiya M
    Am J Physiol; 1992 Nov; 263(5 Pt 1):G719-25. PubMed ID: 1443147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of ammonia-monochloramine system in Helicobacter pylori--induced gastric mucosal injury].
    Suzuki M; Miura S
    Nihon Rinsho; 1993 Dec; 51(12):3154-8. PubMed ID: 8283624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonopsonic activation of neutrophils by Helicobacter pylori is inhibited by rebamipide.
    Danielsson D; Jurstrand M
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):167S-173S. PubMed ID: 9753245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of rebamipide on the neutrophil adherence stimulated by conditioned media from Helicobacter pylori-infected gastric epithelial cells.
    Kim CD; Kim HH; Hong KW
    J Pharmacol Exp Ther; 1999 Jan; 288(1):133-8. PubMed ID: 9862763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antioxidant effect of rebamipide on oxygen free radical production by H. pylori-activated human neutrophils: in comparison with N-acetylcysteine, ascorbic acid and glutathione.
    Hong WS; Jung HY; Yang SK; Myung SJ; Kim JH; Min YI; Chung MH; Lee HS; Kim HW
    Pharmacol Res; 2001 Oct; 44(4):293-7. PubMed ID: 11592863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebamipide protects against activation of neutrophils by Helicobacter pylori.
    Yoshida N; Yoshikawa T; Iinuma S; Arai M; Takenaka S; Sakamoto K; Miyajima T; Nakamura Y; Yagi N; Naito Y; Mukai F; Kondo M
    Dig Dis Sci; 1996 Jun; 41(6):1139-44. PubMed ID: 8654144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells.
    Hayashi S; Sugiyama T; Amano K; Isogai H; Isogai E; Aihara M; Kikuchi M; Asaka M; Yokota K; Oguma K; Fujii N; Hirai Y
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1895-9. PubMed ID: 9687380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rebamipide on gastric cell damage by Helicobacter pylori-stimulated human neutrophils.
    Han BG; Kim HS; Rhee KH; Han HS; Chung MH
    Pharmacol Res; 1995 Oct; 32(4):201-7. PubMed ID: 8866835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro studies indicating antioxidative properties of rebamipide.
    Iinuma S; Naito Y; Yoshikawa T; Takahashi S; Takemura T; Yoshida N; Kondo M
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):35S-39S. PubMed ID: 9753224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lipid peroxidation, NF-kappaB activation and IL-8 production by rebamipide in Helicobacter pylori-stimulated gastric epithelial cells.
    Kim H; Seo JY; Kim KH
    Dig Dis Sci; 2000 Mar; 45(3):621-8. PubMed ID: 10749342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells.
    Masamune A; Yoshida M; Sakai Y; Shimosegawa T
    J Pharmacol Exp Ther; 2001 Aug; 298(2):485-92. PubMed ID: 11454909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive effect of rebamipide on gastric mucosal cell damage evoked by activation of formyl-methionyl-leucyl-phenylalanine receptors of rabbit neutrophils.
    Kim CD; Hong KW
    J Pharmacol Exp Ther; 1997 Apr; 281(1):478-83. PubMed ID: 9103534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of rebamipide on the expression of proinflammatory mediators and apoptosis in human neutrophils by Helicobacter pylori water-soluble surface proteins.
    Kim JS; Kim JM; Jung HC; Song IS
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():45-54. PubMed ID: 12925140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of rebamipide on induction of heat-shock proteins and protection against reactive oxygen metabolite-mediated cell damage in cultured gastric mucosal cells.
    Hahm KB; Park IS; Kim YS; Kim JH; Cho SW; Lee SI; Youn JK
    Free Radic Biol Med; 1997; 22(4):711-6. PubMed ID: 9013134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats.
    Ogino K; Hobara T; Ishiyama H; Yamasaki K; Kobayashi H; Izumi Y; Oka S
    Eur J Pharmacol; 1992 Feb; 212(1):9-13. PubMed ID: 1313372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of attenuating effects of rebamipide, an anti-ulcer agent, on oxidative burst of human neutrophils.
    Shimoyama T; Fukuda S; Liu Q; Fukuda Y; Nakaji S; Sugawara K
    J Pharmacol Sci; 2003 Feb; 91(2):153-7. PubMed ID: 12686760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rebamipide on H. pylori-associated gastric mucosal injury in Mongolian gerbils.
    Suzuki H; Mori M; Kai A; Suzuki M; Suematsu M; Miura S; Ishii H
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):181S-187S. PubMed ID: 9753247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats.
    Murakami K; Okajima K; Harada N; Isobe H; Okabe H
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):139S-142S. PubMed ID: 9753240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing.
    Arakawa T; Kobayashi K; Yoshikawa T; Tarnawski A
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):5S-13S. PubMed ID: 9753220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.